MMR vaccine - Berna Biotech
Alternative Names: Measles-mumps-rubella-vaccine-Berna BiotechLatest Information Update: 02 Oct 2021
At a glance
- Originator Berna Biotech
- Class Measles vaccines; Rubella vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Measles; Mumps; Rubella
Most Recent Events
- 30 Nov 2003 Phase-III clinical trials in Measles in Switzerland (Injection)
- 30 Nov 2003 Phase-III clinical trials in Mumps in Switzerland (Injection)
- 30 Nov 2003 Phase-III clinical trials in Rubella in Switzerland (Injection)